And now the truth about the potential for this stock. Watch for all kinds of short attacks, but it won't matter...
Under Methuselah's University 3D Bioprinter Program, Methuselah is donating at least $500,000 in direct funding to be divided among several institutions for Organovo bioprinter research projects. This funding will cover budgeted bioprinter costs, as well as other aspects of project execution.
At any given time, the waiting lists for critical organ transplants are three to five times as long as the list of available organs. In addition, other transplantable tissues, such as blood vessels, lung, and bone, are also in high demand with few sources.
One of my friends has adult onset Diabetes and she asked me if they'll be able to print her a pancreas. I would venture to say, yes eventually, especially with this news.
"Developing organs for surgical implantation will take meaningful efforts and focused partnerships. This collaboration with Yale, which combines their expertise and technology with our own, is one important step in progressing towards implantable, therapeutic tissues," said Keith Murphy, chairman and CEO of Organovo.
This will accelerate the creation of implantable tissues, and very soon people will start to realize how fast this is going to happen.
Organovo will erase the waiting lists for donor organs. It's that simple.
Just imagine how many people will benefit from this. It's simply mind boggling.
Just sayin...
AI
Market Data 
Markets 
